WEBINAR: IT SOMETIMES GETS TOXIC ON MY EMERGENCY SHIFT...23. APRIL, KL 19.00

Orion Pharma Animal Health inviterer veterinærer til et spennende webinar i samarbeid med Succes i Veterinær Praksis.

:: INVITASJON

• INTRODUKSJON

• HOW TO DECONTAMINATE THEPOISONED PATIENT

Bert Jan Reezigt, DVM, Swedish specialist indiseases of dogs and cats.

...SOME SMALL ANIMAL INTOXICATIONS EXPLAINED

DATO & TID: TORSDAG 23. APRIL, KL 19.00

PROGRAM (19.00 - ca. 20.30)

Bert Jan graduated from Utrecht University in 1997 and moved from Holland to live and work in Sweden. Since 2003 he is employed at “Blå Stjär-nans Djursjukhus”, a small animal specialist referral hospital in Gothenburg, Sweden. For many years he was head of ICU and part of the hospitals manage-ment team. He is a Swedish board certified specia-list in diseases of dogs and cats. His main areas of interest are ECC, internal medicine and ultrasound. From 2006-2016 he was a member of the general board of EVECCS and working actively to promote

ECC in Europe. Nowadays he works as a veterinarian specialized in ECC and he is consulting in internal medicine. He is chair of the “Nordic Small Animal Veterinary Conference” and leader of the Blue Star Academy. He frequent-ly lectures in Scandinavian countries, mainly on ECC topics. Because of his work at the emergency service and ICU he has good experience in small animal toxicology care.

Heidi graduated in 2008 from Helsinki School of Economics, where she majored in Entrepreneurship and SME Management and minored in Marketing, Information Technology and Business Law. She wrote her Master’s Thesis on marketing of veterinary services. She then pursued her Licentiate of Veterinary Medicine (DVM) degree in the Faculty of Veterinary Medicine at the Uni-versity of Helsinki, from where she graduated in 2015 with a the-sis on gene expression of Clostridium botulinum under different environmental stress conditions. In January 2017, Heidi took the position of Global Marketing Manager in Orion Pharma Animal Health, her tasks including providing both scientific, technical

and marketing support to Orion’s own country teams and distributing partners world-wide. Heidi currently works with Clevor, ToxBuddy, Dexdomitor, Domitor, Antisedan, and Domosedan. Additionally, she’s a member of different cross-functional project teams exploring and developing new exciting product and service concepts for our veterinary clients.

• PRODUCT PRESENTATIONCLEVOR® A NEW WAY TO INDUCE EMESIS IN DOGS

Heidi Järvimäki, DVM, MSc (Econ.). Global MarketingManager, Orion Pharma Animal Health headquarters,Espoo, Finland

• SPØRSMÅL

Bruk følgende link for å melde deg på:http://sivp.dk/oriontraining

PÅMELDINGDirektelink: Kontakt Martine Hansen for eventuelle spørsmål:

E-mail: orionvet@orionpharma.comTlf: +45 86 14 00 00

FØRSTE EMETIKUM SOM

ØYEDRÅPER

04/2020 | ©Orion Pharma Animal HealthP.O.Box 4366 Nydalen, 0402 OsloTelefon 40 00 41 90 | www.orionvet.no

Clevor «Orion»Dopaminagonist. Reseptgruppe C. ATCvet-nr.: QN04B C04.

ØYEDRÅPER, oppløsning i endosebeholder 30 mg/ml til hund: 1 ml inneh.: Ropinirol 30 mg, sitronsyremonohydrat, natriumsitrat, natriumklorid, natriumhydroksid, saltsyre, vann til injeksjonsvæsker. Egenskaper: Virkningsmekanisme: Emetisk effekt gjennom selek-tiv aktivering av D2-lignende reseptorer i hjernens area postrema, som sender impulser videre til breknings senteret. Absorpsjon: Rask, oppkast starter etter 4-6 minutter, Tmax nås etter 10-20 minutter. Biotilgjengelighet 23%. Proteinbinding: Lav (37%). Fordeling: Rask, Vd 5,6 liter/kg ved i.v. administrering. Halveringstid: 4 timer. Metabolisme: I lever. Utskillelse: Primært som metabolitter via urin. Indikasjoner: Induksjon av oppkast hos hund. Kontraindikasjoner: Overfølsomhet for innholdsstoffene. Nedsatt aktivitet i CNS, anfall eller andre nevrologiske problemer som kan gi aspira sjonspneumoni. Hypoksi, dyspné eller mangel på svelgerefleks. Skal ikke brukes etter inntak av skarpe gjenstander, etsende stoffer (syrer/alkalier), flyktige stoffer eller organiske løsemidler. Bivirkninger: Svært vanlige (≥1/10): Forbigående mild til moderat hyperemi i øyet, rennende øyne, fremfall av 3. øyelokk, blefarospasme, slapphet og økt hjerte-frekvens. Vanlige (≥1/100 til